Takeda Pharmaceutical TAK
$21.77 +$0.36 (+1.68%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $22.09 +1.47%
Open$21.82
Prev close$21.41
Day range$21.74 – $22.07
Volume3.80M
Market cap$69.76B
P/E (TTM)311.0
Dividend yield1.44%
Fundamentals
Latest reported quarter: Q2, ended Sep 2026 · reported in JPY
Revenue¥1.19T+6.7% YoY
Operating profit¥285.14B+195.7% YoY
Net profit¥192.46B+1,740.9% YoY
Diluted EPS¥59.49+1,619.5% YoY
Free cash flow¥248.55B-23.6% YoY
Operating cash flow¥304.27B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin65.8%
Operating margin14.3%
Net margin0.9%
Return on equity0.6%
Return on assets0.3%
Return on invested capital1.1%
Current ratio1.15
Liabilities / assets51.4%
Cash & investments¥454.40B
Total debt¥4.58T
Net cash (debt)-¥4.12T
Free cash flow / sales9.2%
Where the revenue comes from
Quarter 2027/Q1
By business line
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2027 Q2 (JPY) |
2027 Q1 (JPY) |
2026 ANNUAL (JPY) |
2026 Q4 (JPY) |
2026 Q3 (JPY) |
|---|---|---|---|---|---|
| Total Revenue as Reported | ¥1.19T | ¥1.22T | ¥4.51T | ¥1.09T | ¥1.19T |
| Total Operating Revenue | ¥1.19T | ¥1.22T | ¥4.51T | ¥1.09T | ¥1.19T |
| Cost of Revenue | ¥392.09B | ¥406.68B | ¥1.57T | ¥405.70B | ¥401.15B |
| Gross Profit | ¥795.00B | ¥813.22B | ¥2.93T | ¥688.84B | ¥790.55B |
| Operating Expense | ¥509.86B | ¥611.81B | ¥2.47T | ¥646.77B | ¥649.16B |
| Selling and Admin Expenses | ¥271.71B | ¥286.51B | ¥1.08T | ¥292.00B | ¥282.78B |
| Research & Development | ¥171.23B | ¥167.40B | ¥675.92B | ¥195.32B | ¥175.23B |
| Depreciation & Amortization & Depletion | ¥107.59B | ¥110.93B | ¥633.54B | ¥154.84B | ¥141.91B |
| -Depreciation & Amortization | ¥107.59B | ¥110.93B | ¥633.54B | ¥154.84B | ¥141.91B |
| Other Operating Expenses | -¥40.67B | ¥46.97B | ¥76.00B | ¥4.62B | ¥49.23B |
| Operating Profit | ¥285.14B | ¥201.42B | ¥464.45B | ¥42.07B | ¥141.39B |
| Net Non-Operating Interest Income (Expense) | -¥48.81B | -¥39.24B | -¥143.77B | -¥35.88B | -¥35.76B |
| Non-Operating Interest Income | ¥14.57B | ¥24.61B | ¥16.88B | -¥189.15B | ¥87.87B |
| Non-Operating Interest Expense | ¥63.38B | ¥63.85B | ¥148.12B | -¥165.80B | ¥123.63B |
| Other Income (Expense) | -¥80.36B | ¥538.00M | -¥463.03B | -¥461.22B | ¥28.23B |
| Earnings from Equity Interest | -¥542.00M | ¥538.00M | -¥2.18B | -¥361.00M | ¥799.00M |
| Pretax Profit | ¥155.97B | ¥162.72B | -¥142.36B | -¥455.02B | ¥133.86B |
| Tax | -¥36.49B | ¥49.46B | ¥9.77B | -¥86.62B | ¥30.13B |
| Net Profit | ¥192.46B | ¥113.26B | -¥152.13B | -¥368.41B | ¥103.73B |
| Profit from Continuing Operations | ¥192.46B | ¥113.26B | -¥152.13B | -¥368.41B | ¥103.73B |
| Minority Interests | ¥29.00M | ¥60.00M | ¥264.00M | ¥62.00M | ¥94.00M |
| Net Income to Parent Company | ¥192.43B | ¥113.20B | -¥152.39B | -¥368.47B | ¥103.64B |
| Net Income to Common Stockholders | ¥192.43B | ¥113.20B | -¥152.39B | -¥368.47B | ¥103.64B |
| Basic EPS | ¥60.44 | ¥35.83 | -¥48.38 | -¥117.03 | ¥32.87 |
| Diluted EPS | ¥59.49 | ¥35.27 | -¥48.38 | -¥117.03 | ¥32.34 |
| Dividend Per Share | ¥0.00 | ¥0.00 | ¥97.15 | ¥49.28 | ¥0.00 |
| Total Other Finance Costs | – | – | ¥12.53B | – | – |
| Gain on Sale of Security | – | – | ¥6.14B | – | – |
| Special Income (Charges) | – | – | -¥466.99B | – | – |
| -Less:Restructuring and Mergern & Acquisition | – | – | ¥71.82B | – | – |
| -Less:Other Special Charges | – | – | ¥412.23B | – | – |
| -Less:Write Off | – | – | ¥1.36B | – | – |
| -Gain on Sale Of Business | – | – | ¥18.27B | – | – |
| -Gain on Sale of Property/Plant/Equipment | – | – | ¥165.00M | – | – |
Balance sheet
| Line item | 2027 Q2 (JPY) |
2027 Q1 (JPY) |
2026 ANNUAL (JPY) |
2026 Q4 (JPY) |
2026 Q3 (JPY) |
|---|---|---|---|---|---|
| Total Assets | ¥15.27T | ¥15.66T | ¥15.51T | ¥15.51T | ¥15.41T |
| Total Current Assets | ¥3.00T | ¥3.15T | ¥3.09T | ¥3.09T | ¥3.12T |
| Cash and Cash Equivalents & Short-Term Investments | ¥454.40B | ¥527.58B | ¥636.94B | ¥636.94B | ¥761.94B |
| -Cash and Cash Equivalents | ¥418.53B | ¥460.98B | ¥595.05B | ¥595.05B | ¥654.94B |
| -Short Term Investments | ¥35.87B | ¥66.60B | ¥41.89B | ¥41.89B | ¥107.00B |
| Receivables | ¥910.25B | ¥956.14B | ¥876.35B | ¥876.35B | ¥757.92B |
| -Accounts Receivable | ¥872.68B | ¥930.38B | ¥977.36B | ¥977.36B | ¥736.46B |
| -Taxes Receivable | ¥37.56B | ¥25.76B | ¥32.04B | ¥32.04B | ¥21.46B |
| Inventory | ¥1.44T | ¥1.45T | ¥1.40T | ¥1.40T | ¥1.41T |
| Other Current Assets | ¥178.08B | ¥188.78B | ¥162.64B | ¥162.64B | ¥175.78B |
| Total Non-Current Assets | ¥12.27T | ¥12.51T | ¥12.42T | ¥12.42T | ¥12.29T |
| Net PPE | ¥2.28T | ¥2.14T | ¥2.12T | ¥2.12T | ¥2.08T |
| Investments and Advances | ¥408.26B | ¥473.22B | ¥448.74B | ¥448.74B | ¥434.17B |
| -Available for Sale Securities | ¥399.64B | ¥463.14B | ¥439.94B | ¥439.94B | ¥423.98B |
| -Long Term Equity Investment | ¥8.62B | ¥10.08B | ¥8.80B | ¥8.80B | ¥10.19B |
| Goodwill and Other Intangible Assets | ¥8.90T | ¥9.28T | ¥9.23T | ¥9.23T | ¥9.27T |
| -Goodwill | ¥5.68T | ¥5.89T | ¥5.81T | ¥5.81T | ¥5.75T |
| -Other Intangible Assets | ¥3.22T | ¥3.39T | ¥3.42T | ¥3.42T | ¥3.52T |
| Non-Current Deferred Assets | ¥607.52B | ¥539.15B | ¥546.26B | ¥546.26B | ¥427.49B |
| Other Non-Current Assets | ¥74.10B | ¥80.30B | ¥77.01B | ¥77.01B | ¥77.80B |
| Total Liabilities | ¥7.85T | ¥8.10T | ¥8.08T | ¥8.08T | ¥7.76T |
| Total Current Liabilities | ¥2.60T | ¥2.76T | ¥2.83T | ¥2.83T | ¥2.61T |
| Payables | ¥603.28B | ¥564.72B | ¥589.23B | ¥589.23B | ¥615.93B |
| -Accounts Payable | ¥486.20B | ¥446.78B | ¥324.37B | ¥324.37B | ¥467.59B |
| -Total Tax Payable | ¥117.08B | ¥117.93B | ¥97.88B | ¥97.88B | ¥148.34B |
| Short-Term Debt and Capital Lease Obligation | ¥400.97B | ¥519.97B | ¥512.16B | ¥512.16B | ¥583.15B |
| -Current Debt | ¥400.97B | ¥519.97B | ¥512.16B | ¥512.16B | ¥583.15B |
| Current Provisions | ¥962.14B | ¥995.05B | ¥998.50B | ¥998.50B | ¥572.13B |
| Other Current Liabilities | ¥637.16B | ¥684.81B | ¥732.19B | ¥732.19B | ¥838.98B |
| Total Non-Current Liabilities | ¥5.25T | ¥5.34T | ¥5.25T | ¥5.25T | ¥5.15T |
| Long Term Debt and Capital Lease Obligation | ¥4.17T | ¥4.42T | ¥4.37T | ¥4.37T | ¥4.27T |
| -Long Term Debt | ¥4.17T | ¥4.42T | ¥4.37T | ¥4.37T | ¥4.27T |
| Non-Current Liabilities | ¥34.38B | ¥37.93B | ¥37.55B | ¥37.55B | ¥34.06B |
| Non-Current Deferred Liabilities | ¥24.29B | ¥27.04B | ¥26.80B | ¥26.80B | ¥31.28B |
| Employee Benefits | ¥132.19B | ¥141.79B | ¥143.68B | ¥143.68B | ¥150.60B |
| Other Non-Current Liabilities | ¥885.24B | ¥713.09B | ¥671.07B | ¥671.07B | ¥665.12B |
| Total Equity | ¥7.42T | ¥7.56T | ¥7.43T | ¥7.43T | ¥7.64T |
| Stockholders' Equity | ¥7.42T | ¥7.56T | ¥7.43T | ¥7.43T | ¥7.64T |
| Capital Stock | ¥1.72T | ¥1.70T | ¥1.70T | ¥1.70T | ¥1.69T |
| -Common Stock | ¥1.72T | ¥1.70T | ¥1.70T | ¥1.70T | ¥1.69T |
| Additional Paid-In Capital | ¥1.76T | ¥1.79T | ¥1.78T | ¥1.78T | ¥1.75T |
| Retained Earnings | ¥859.25B | ¥667.01B | ¥712.38B | ¥712.38B | ¥1.10T |
| Less: Treasury Stock | -¥20.91B | -¥47.44B | -¥49.13B | -¥49.13B | -¥49.12B |
| Gains/Losses Not Affecting Retained Earnings | -¥3.22B | -¥11.06B | -¥2.85B | -¥2.85B | -¥2.94B |
| Other Equity Interests | ¥3.10T | ¥3.46T | ¥3.30T | ¥3.30T | ¥3.15T |
| Minority Interests | ¥991.00M | ¥989.00M | ¥1.21B | ¥1.21B | ¥1.15B |
| -Other Receivables | – | – | ¥36.29B | ¥36.29B | – |
| -Receivables Adjustments Allowances | – | – | -¥169.33B | -¥169.33B | – |
| -Gross PPE | – | – | ¥3.65T | ¥3.65T | – |
| -Accumulated Depreciation | – | – | -¥1.53T | -¥1.53T | – |
| -Other Payable | – | – | ¥166.98B | ¥166.98B | – |
| Long Term Accounts Payable and Other Payables | – | – | – | – | ¥3.27B |
Cash flow
| Line item | 2027 Q2 (JPY) |
2027 Q1 (JPY) |
2026 ANNUAL (JPY) |
2026 Q4 (JPY) |
2026 Q3 (JPY) |
|---|---|---|---|---|---|
| Operating Cash Flow | ¥304.27B | ¥127.62B | ¥1.04T | ¥74.53B | ¥373.25B |
| Net cash flow from continuing operations | ¥304.27B | ¥127.62B | ¥1.04T | ¥74.53B | ¥373.25B |
| Net Income from Continuing Operations | ¥192.46B | ¥113.26B | -¥152.13B | -¥368.41B | ¥103.73B |
| Gain/Loss from Continuing Operations | ¥9.38B | -¥6.54B | -¥13.02B | ¥1.82B | -¥441.00M |
| Depreciation & Depletion & Amortization | ¥164.43B | ¥163.04B | ¥721.13B | ¥163.87B | ¥190.64B |
| Deferred Tax | -¥36.49B | ¥49.46B | ¥9.77B | -¥86.62B | ¥30.13B |
| Other Non-Cash Items | ¥2.38B | -¥44.76B | ¥228.84B | ¥106.40B | ¥85.09B |
| Change in Working Capital | ¥11.69B | -¥181.57B | ¥199.91B | ¥251.00B | -¥39.33B |
| -Change in Receivables | ¥40.65B | -¥70.97B | -¥70.17B | -¥97.52B | -¥10.94B |
| -Change in Inventory | -¥42.25B | -¥33.41B | -¥61.29B | ¥18.70B | -¥37.96B |
| -Change in Payables and Accrued Expense | ¥9.27B | -¥22.91B | -¥3.15B | ¥4.80B | ¥3.29B |
| -Change in Other Current Liabilities | ¥6.34B | -¥34.91B | -¥81.61B | -¥96.37B | ¥20.07B |
| -Change In Other Working Capital | -¥2.33B | -¥19.38B | ¥416.12B | ¥421.38B | -¥13.79B |
| Net cash flow from investing | -¥21.07B | -¥87.70B | -¥369.14B | -¥58.02B | -¥229.80B |
| Net Cash Flow from Continuing Investing Activities | -¥21.07B | -¥87.70B | -¥369.14B | -¥58.02B | -¥229.80B |
| Net PPE Purchase and Sale | -¥44.33B | -¥52.72B | -¥169.55B | -¥46.31B | -¥41.62B |
| Net Intangibles Purchase and Sale | -¥11.03B | -¥49.43B | -¥238.66B | -¥18.03B | -¥180.74B |
| Net Business Purchase and Sale | ¥12.07B | ¥10.46B | ¥33.58B | ¥515.00M | ¥3.36B |
| Net Investment Purchase and Sale | ¥17.03B | -¥747.00M | -¥10.40B | ¥723.00M | -¥13.37B |
| Net Other Investing Changes | ¥698.00M | -¥244.00M | -¥2.78B | -¥51.00M | -¥2.64B |
| Financing Cash Flow | -¥311.02B | -¥180.35B | -¥496.82B | -¥77.49B | -¥192.45B |
| Net Cash Flow from Continuing Financing Activities | -¥311.02B | -¥180.35B | -¥496.82B | -¥77.49B | -¥192.45B |
| Net Issuance Payments Of Debt | -¥250.02B | -¥11.29B | ¥1.08B | -¥25.62B | -¥9.89B |
| Net Common Stock Issuance | ¥0.00 | -¥1.01B | -¥51.60B | ¥0.00 | ¥0.00 |
| Cash Dividends Paid | -¥7.73B | -¥150.13B | -¥311.90B | -¥8.79B | -¥149.03B |
| Net Other Financing Charges | -¥2.40B | -¥2.35B | -¥13.01B | -¥3.79B | -¥3.74B |
| Ending Cash Balance | ¥418.53B | ¥460.98B | ¥595.05B | ¥595.05B | ¥654.94B |
| Net Change in Cash | -¥27.83B | -¥140.43B | ¥175.47B | -¥60.98B | -¥48.99B |
| Beginning Cash Balance | ¥460.98B | ¥595.05B | ¥385.11B | ¥654.94B | ¥681.49B |
| Effect of Exchange Rate Changes | -¥14.62B | ¥6.36B | ¥34.47B | ¥1.10B | ¥22.44B |
| Free Cash Flow | ¥248.55B | ¥24.39B | ¥626.77B | ¥10.14B | ¥150.88B |
No comments yet — be the first to weigh in on TAK.
Sign in to join the discussion.